Relay Therapeutics, Inc. RLAY
- zovegalisib — Breast Cancer Phase 3
- zovegalisib — PIK3CA-Related Overgrowth Spectrum Phase 2
- zovegalisib — Vascular Anomalies Phase 2
PI3Kα (2 companies · 4 programs)
Companies with an active program directed at PI3Kα.
Cogent Biosciences, Inc. COGT
- CGT6297 — Advanced Solid Tumors Phase 1